Medicinal composition as a remedy for nonsmall cell lung cancer

Details Medicinal composition as a remedy for nonsmall cell lung cancer Medicinal composition as a remedy for nonsmall cell lung cancer

A - Human Necessities

61

K

A61K 31/70 (2006.01) C07H 17/00 (2006.01) C07H 17/08 (2006.01)

Patent

CA 2189001

14- or 15-membered-ring macrolide compounds such as clarithromycin, erythromycin B, etc. have a potent antitumor effect on non-small cell lung cancers which are considered the most difficult tumors to be be subjected to surgical operation and chemotherapy, and are useful as a practical therapeutic agent of non-small cell lung cancer.

Des composés macrolides à quatorze et quinze branches tels que la clarithromycine et l'érythromicyne B ont une puissante action antitumorale contre le cancer bronchopulmonaire "non à petites cellules" qui est considéré comme l'une des tumeurs les plus difficiles à traiter par chirurgie ou chimiothérapie. Ces composés sont donc des médicaments utiles et commodes contre cette affection.

Affiliated with

Also associated with

Rating

Medicinal composition as a remedy for nonsmall cell lung cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicinal composition as a remedy for nonsmall cell lung cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicinal composition as a remedy for nonsmall cell lung cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1651986